Composition: Each tablet contains: Chymotrypsin 300 E.A.U. (14 micro Katals). Trypsin 300 E.A.U. (5 micro Katals). Excipient q.s. ad one coated tablet of 0.24g , gastroresistant and enterosoluble.
Properties: alphintern® has a synergistic, anti-inflammatory and anti-edematous action of two potent proteolytic enzymes, affecting the exudative phase of inflammation and ensuring the destruction of peptidic chains in inflammatory processes, regardless of the origin. The gastroresistant and enterosoluble coating of alphintern® tablets ensures best tolerance as well as best efficiency due to its absorption in the intestine only.
Indications And Usage: - Inflammatory conditions and related pain regardless of the origin and localization, especially in: Traumatology & Surgery: Preventive and curative treatment of post- traumatic and postoperative edemas and hematomas Sprains, hematomas, sequelae of fractures and postoperative edemas E.N.T.: Pharyngitis, laryngitis, sinusitis, otitis and inflammations of the eustachean tube Ophthalmology: Eye trauma, postoperative and vitreous hemorrhage. Pneumology: Bronchopulmonary inflammations and tracheobronchitis. Stomatology: Teeth extractions, periodontium and gum inflammations, and stomatological and maxillofacial surgery. Gynecology: Pelvic inflammatory diseases, perineal edema and mastitis Alphintern® also improves the diffusion in situ of antibiotics, especially in the E.N.T. bronchopulmonary and stomatological spheres.
Contraindications: Known hypersensitivity to trypsin or chymotrypsin. Precautions In case of infections alphintern® should be associated with antibiotics.
Dosage & Administration: One to two tablets 3 times daily to be swallowed and not chewed, or as prescribed by the physician.
How Supplied: Strips of 10 tablets in packs of 2 or 3 strips.